Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 94
2002 207
2003 234
2004 230
2005 202
2006 178
2007 170
2008 180
2009 163
2010 193
2011 243
2012 276
2013 323
2014 353
2015 471
2016 535
2017 561
2018 511
2019 523
2020 690
2021 665
2022 635
2023 570
2024 245

Text availability

Article attribute

Article type

Publication date

Search Results

7,565 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).
Kaye KS, Shorr AF, Wunderink RG, Du B, Poirier GE, Rana K, Miller A, Lewis D, O'Donnell J, Chen L, Reinhart H, Srinivasan S, Isaacs R, Altarac D. Kaye KS, et al. Lancet Infect Dis. 2023 Sep;23(9):1072-1084. doi: 10.1016/S1473-3099(23)00184-6. Epub 2023 May 11. Lancet Infect Dis. 2023. PMID: 37182534 Clinical Trial.
RTS,S/AS01 malaria vaccine-proven safe and effective?
Björkman A, Benn CS, Aaby P, Schapira A. Björkman A, et al. Lancet Infect Dis. 2023 Aug;23(8):e318-e322. doi: 10.1016/S1473-3099(23)00126-3. Epub 2023 Apr 20. Lancet Infect Dis. 2023. PMID: 37086747 Review.
Hantavirus in humans: a review of clinical aspects and management.
Vial PA, Ferrés M, Vial C, Klingström J, Ahlm C, López R, Le Corre N, Mertz GJ. Vial PA, et al. Lancet Infect Dis. 2023 Sep;23(9):e371-e382. doi: 10.1016/S1473-3099(23)00128-7. Epub 2023 Apr 24. Lancet Infect Dis. 2023. PMID: 37105214 Review.
Infectious diseases surveillance update.
Islam T. Islam T. Lancet Infect Dis. 2023 Dec;23(12):e518. doi: 10.1016/S1473-3099(23)00703-X. Lancet Infect Dis. 2023. PMID: 38006890 No abstract available.
Infectious diseases surveillance update.
Zwizwai R. Zwizwai R. Lancet Infect Dis. 2024 Jan;24(1):e22. doi: 10.1016/S1473-3099(23)00765-X. Lancet Infect Dis. 2024. PMID: 38141651 No abstract available.
Virological characteristics of the SARS-CoV-2 JN.1 variant.
Kaku Y, Okumura K, Padilla-Blanco M, Kosugi Y, Uriu K, Hinay AA Jr, Chen L, Plianchaisuk A, Kobiyama K, Ishii KJ; Genotype to Phenotype Japan (G2P-Japan) Consortium; Zahradnik J, Ito J, Sato K. Kaku Y, et al. Lancet Infect Dis. 2024 Feb;24(2):e82. doi: 10.1016/S1473-3099(23)00813-7. Epub 2024 Jan 3. Lancet Infect Dis. 2024. PMID: 38184005 No abstract available.
Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant.
Yamasoba D, Uriu K, Plianchaisuk A, Kosugi Y, Pan L, Zahradnik J; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Yamasoba D, et al. Lancet Infect Dis. 2023 Jun;23(6):655-656. doi: 10.1016/S1473-3099(23)00278-5. Epub 2023 May 3. Lancet Infect Dis. 2023. PMID: 37148902 Free PMC article. No abstract available.
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H; SABATO study group. Kaasch AJ, et al. Lancet Infect Dis. 2024 Jan 17:S1473-3099(23)00756-9. doi: 10.1016/S1473-3099(23)00756-9. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38244557
7,565 results